Pseudomyxoma peritonei
Clinical trials for Pseudomyxoma peritonei explained in plain language.
Never miss a new study
Get alerted when new Pseudomyxoma peritonei trials appear
Sign up with your email to follow new studies for Pseudomyxoma peritonei, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Common diabetes drug may slow rare abdominal cancer
Disease control Recruiting nowThis trial tests whether metformin, a common diabetes medication, can help people with pseudomyxoma peritonei, a rare cancer that spreads in the abdomen. The study includes adults whose cancer has returned or cannot be surgically removed. Researchers will measure how many partici…
Matched conditions: PSEUDOMYXOMA PERITONEI
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Lower dose of heated chemo may be just as effective for rare abdominal cancer
Disease control Recruiting nowThis study tests whether a lower dose of heated chemotherapy given during surgery works as well as a higher dose for people with pseudomyxoma peritonei, a rare cancer that spreads in the abdomen. About 176 participants will be randomly assigned to receive either the lower dose ov…
Matched conditions: PSEUDOMYXOMA PERITONEI
Phase 3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New vaccine combo takes on rare belly cancer
Disease control Recruiting nowThis early-phase trial tests a cancer vaccine (Pseudovax) combined with an immune booster and an immunotherapy drug in 10 people with pseudomyxoma peritonei, a rare abdominal cancer that has come back or cannot be removed. The goal is to see if the treatment is safe and can react…
Matched conditions: PSEUDOMYXOMA PERITONEI
Early phase 1 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Heated chemo showdown: one round or three for rare belly cancer?
Disease control Recruiting nowThis study tests whether giving three rounds of heated chemotherapy directly into the abdomen after surgery works better than just one round for people with pseudomyxoma peritonei, a rare cancer that spreads in the belly. About 132 adults will be randomly assigned to one or three…
Matched conditions: PSEUDOMYXOMA PERITONEI
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Breathe away the fear: new study tests heart coherence for cancer patients
Symptom relief Recruiting nowThis study tests whether a daily breathing exercise called cardiac coherence can lower anxiety in people awaiting surgery for peritoneal cancer. About 60 participants will either practice the technique or receive standard care. The goal is to see if this simple, drug-free method …
Matched conditions: PSEUDOMYXOMA PERITONEI
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can heated chemotherapy during surgery extend life for peritoneal cancer patients?
Knowledge-focused Recruiting nowThis study collects follow-up data from 125 people with peritoneal surface cancers, including colorectal-origin carcinomatosis, pseudomyxoma peritonei, and peritoneal mesothelioma, who are scheduled for cytoreductive surgery combined with HIPEC. The goal is to track their outcome…
Matched conditions: PSEUDOMYXOMA PERITONEI
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Patient stories could unlock new treatments for rare appendix cancer
Knowledge-focused Recruiting nowThis study is building a global patient registry to collect real-world information from people diagnosed with appendix cancer or pseudomyxoma peritonei (PMP), a rare condition where tumors spread in the abdomen. Participants and caregivers share details about their symptoms, trea…
Matched conditions: PSEUDOMYXOMA PERITONEI
Sponsor: Appendix Cancer Pseudomyxoma Peritonei Research Foundation • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC